Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension

Background— The natriuretic peptide system contributes to blood pressure regulation. Atrial and brain natriuretic peptides are cleaved into smaller biologically active molecules by corin, a transmembrane serine protease expressed in cardiomyocytes. Method and Results— This genotype-phenotype genetic association study included replication samples and genomic control to correct for population stratification. Sequencing of the human corin gene identified 2 nonsynonymous, nonconservative single nucleotide polymorphisms (Q568P and T555I) in near-complete linkage disequilibrium, thus describing a single minor I555 (P568) corin gene allele. This allele was present in the heterozygote state in ≈12% of blacks but was extremely rare in whites (<0.5% were homozygous for the minor allele). In our primary population sample, the Dallas Heart Study, after adjustment for potential confounders, including population stratification, the corin I555 (P568) allele remained independently associated with increased risk for prevalent hypertension (odds ratio, 1.63; 95% CI, 1.11 to 2.38; P=0.013). The corin I555 (P568) allele also was associated with higher systolic blood pressure in subjects not using antihypertensive medication in unadjusted (133.7±20.7 versus 129.4±17.4 mm Hg; P=0.029) and adjusted (132.5±1.6 versus 128.9±0.6 mm Hg; P=0.029) analyses. The independent association of the minor corin allele with increased risk for prevalent hypertension was confirmed in the Multi-Ethnic Study of Atherosclerosis (odds ratio, 1.50; 95% CI, 1.09 to 2.06; P=0.014). In addition, the association of the minor corin I555 (P568) allele with higher systolic blood pressure was confirmed in adjusted analysis in the Chicago Genetics of Hypertension Study (125.8±1.9 versus 121.4±0.7 mm Hg; P=0.03). Conclusions— The corin I555 (P568) allele is common in blacks and is associated with higher blood pressure and an increased risk for prevalent hypertension.

[1]  K. Alestig,et al.  Prediction of glomerular filtration rate from serum creatinine, age, sex and body weight. , 2009, Acta medica Scandinavica.

[2]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[3]  R. Cooper,et al.  Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  T. Nakayama The genetic contribution of the natriuretic peptide system to cardiovascular diseases. , 2005, Endocrine journal.

[5]  N. Risch,et al.  Admixture mapping for hypertension loci with genome-scan markers , 2005, Nature Genetics.

[6]  W. Dole,et al.  Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Grundy,et al.  African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. , 2004, Journal of the American College of Cardiology.

[8]  M. R. Madlansacay,et al.  Identification of Domain Structures in the Propeptide of Corin Essential for the Processing of Proatrial Natriuretic Peptide* , 2004, Journal of Biological Chemistry.

[9]  Celeste M Condit,et al.  Genetic research and health disparities. , 2004, JAMA.

[10]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[11]  Xiaofeng Zhu,et al.  Linkage analysis of a complex disease through use of admixed populations. , 2004, American journal of human genetics.

[12]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[13]  T. Marshall When measurements are misleading: modelling the effects of blood pressure misclassification in the English population , 2004, BMJ : British Medical Journal.

[14]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[15]  M. Rieder,et al.  An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population , 2003, Journal of hypertension.

[16]  J. Cockcroft,et al.  Atrial Natriuretic Peptide Regulates Regional Vascular Volume and Venous Tone in Humans , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[18]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[19]  Junliang Pan,et al.  Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes* , 2002, The Journal of Biological Chemistry.

[20]  J. Bełtowski,et al.  Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[21]  J. Clements,et al.  Type II Transmembrane Serine Proteases , 2001, The Journal of Biological Chemistry.

[22]  J. Morser,et al.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  U. Ackermann,et al.  ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. , 2000, Physiological genomics.

[24]  K. Roeder,et al.  The power of genomic control. , 2000, American journal of human genetics.

[25]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[26]  N. Maeda,et al.  Hypertension Associated with Decreased Testosterone Levels in Natriuretic Peptide Receptor-A Gene-Knockout and Gene-Duplicated Mutant Mouse Models1. , 1999, Endocrinology.

[27]  J. Morser,et al.  Corin, a Mosaic Transmembrane Serine Protease Encoded by a Novel cDNA from Human Heart* , 1999, The Journal of Biological Chemistry.

[28]  J. Burnett,et al.  Vasopeptidase inhibition: a new concept in blood pressure management. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[29]  H. S. Kim,et al.  Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Ordunez,et al.  Evaluation of an electronic blood pressure device for epidemiological studies. , 1997, Blood pressure monitoring.

[31]  Daniel L. McGee,et al.  The prevalence of hypertension in seven populations of west African origin. , 1997, American journal of public health.

[32]  T. Forrester,et al.  Standardization of blood pressure measurement in an international comparative study. , 1996, Journal of clinical epidemiology.

[33]  J. Witte,et al.  Genetic dissection of complex traits , 1996, Nature Genetics.

[34]  Y. Matsuda,et al.  A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. , 1995, The Journal of clinical investigation.

[35]  J. Murgo,et al.  Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. , 1994, Circulation research.

[36]  F. Mee,et al.  Inaccuracy of seven popular sphygmomanometers for home measurement of blood pressure. , 1990, Journal of hypertension.

[37]  J. Floras Sympathoinhibitory effects of atrial natriuretic factor in normal humans. , 1990, Circulation.

[38]  J. Burnett The atrial peptide system in cardiac disease. , 1988, American journal of hypertension.

[39]  A. Aviv,et al.  The Na+/H+ antiport, cytosolic free Ca2+, and essential hypertension: a hypothesis. , 1988, American journal of hypertension.

[40]  D. Ganten,et al.  Atrial natriuretic peptide: a new factor in blood pressure control. , 1987, Journal of hypertension.

[41]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[42]  N. Schork,et al.  The future of genetic case-control studies. , 2001, Advances in genetics.

[43]  R. Nusse,et al.  WNT targets. Repression and activation. , 1999, Trends in genetics : TIG.

[44]  N. Maeda,et al.  Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. , 1999, Endocrinology.

[45]  E. Lander,et al.  Genetic dissection of complex traits science , 1994 .